SETDB-1: A Potential Epigenetic Regulator in Breast Cancer Metastasis
The full epigenetic repertoire governing breast cancer metastasis is not completely understood. Here, we discuss the histone methyltransferase SET Domain Bifurcated Histone Lysine Methyltransferase 1 (SETDB1) and its role in breast cancer metastasis. SETDB1 serves as an exemplar of the difficulties...
Main Authors: | Jacob Batham, Pek Siew Lim, Sudha Rao |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-08-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/11/8/1143 |
Similar Items
-
Structure, Activity and Function of the SETDB1 Protein Methyltransferase
by: Mariam Markouli, et al.
Published: (2021-08-01) -
The Updating of Biological Functions of Methyltransferase SETDB1 and Its Relevance in Lung Cancer and Mesothelioma
by: Li Yuan, et al.
Published: (2021-07-01) -
Histone methyltransferase SETDB1 is required for prostate cancer cell proliferation, migration and invasion
by: Yi Sun, et al.
Published: (2014-04-01) -
Emerging roles of H3K9me3, SETDB1 and SETDB2 in therapy-induced cellular reprogramming
by: Joachim Torrano, et al.
Published: (2019-03-01) -
Oncogenic Roles Of A Histone Methyltransferase SETDB2 In AML1-ETO Positive AML
by: Mu G, et al.
Published: (2020-02-01)